Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
BWXT 
BWX Technologies Inc (BWXT)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: BWXT (5-star) is a STRONG-BUY. BUY since 75 days. Profits (60.29%). Updated daily EoD!
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
11 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $181.5
1 Year Target Price $181.5
| 6 | Strong Buy |
| 3 | Buy |
| 1 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 105.66% | Avg. Invested days 61 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 15.97B USD | Price to earnings Ratio 54.42 | 1Y Target Price 181.5 |
Price to earnings Ratio 54.42 | 1Y Target Price 181.5 | ||
Volume (30-day avg) 11 | Beta 0.72 | 52 Weeks Range 84.02 - 189.25 | Updated Date 08/15/2025 |
52 Weeks Range 84.02 - 189.25 | Updated Date 08/15/2025 | ||
Dividends yield (FY) 0.55% | Basic EPS (TTM) 3.21 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-04 | When - | Estimate 0.79 | Actual 1.02 |
Profitability
Profit Margin 10.28% | Operating Margin (TTM) 11.24% |
Management Effectiveness
Return on Assets (TTM) 6.12% | Return on Equity (TTM) 27.01% |
Valuation
Trailing PE 54.42 | Forward PE 52.91 | Enterprise Value 17462603878 | Price to Sales(TTM) 5.57 |
Enterprise Value 17462603878 | Price to Sales(TTM) 5.57 | ||
Enterprise Value to Revenue 6.1 | Enterprise Value to EBITDA 35.49 | Shares Outstanding 91398704 | Shares Floating 90991102 |
Shares Outstanding 91398704 | Shares Floating 90991102 | ||
Percent Insiders 0.4 | Percent Institutions 97.85 |
Upturn AI SWOT
BWX Technologies Inc
Company Overview
History and Background
BWX Technologies, Inc. (BWXT) was founded in 2010 as a spin-off from Babcock & Wilcox. It traces its roots back to the early 1800s. It designs, manufactures, and services nuclear components and provides nuclear fuel for reactors.
Core Business Areas
- Nuclear Operations Group: Manufactures nuclear components for U.S. Navy submarines and aircraft carriers, as well as for commercial nuclear power plants.
- Nuclear Services Group: Provides nuclear fuel services, waste processing, and environmental remediation services. Manages and operates government-owned nuclear facilities.
- Medical Isotopes: Produces medical isotopes for diagnostic and therapeutic applications. Seeking to expand footprint in this segment.
Leadership and Structure
Rex D. Geveden serves as the President and Chief Executive Officer. BWXT has a structured organizational hierarchy with distinct business segments and corporate functions.
Top Products and Market Share
Key Offerings
- Naval Nuclear Reactors: Manufactures reactors for U.S. Navy submarines and aircraft carriers. BWXT is a sole supplier for this product. Competitors are practically non-existent here as they are the only supplier to the U.S. Navy.
- Nuclear Fuel Services: Provides nuclear fuel processing and enrichment services. Market share is smaller for commercial fuel, competitors include Cameco and Orano.
- Medical Isotopes (Technetium-99m Generators): Produces medical isotopes for medical imaging. Market share is evolving; competitors include Curium Pharma and NorthStar Medical Radioisotopes.
Market Dynamics
Industry Overview
The nuclear market is characterized by high barriers to entry, stringent regulations, and long-term contracts. Demand is driven by defense spending, nuclear power plant maintenance, and the growing medical isotope market.
Positioning
BWXT holds a leading position in the naval nuclear reactor market and a significant presence in nuclear fuel services. Its medical isotope business is growing.
Total Addressable Market (TAM)
The total addressable market for BWXT's core segments is estimated to be in the tens of billions of dollars annually. BWXT has a strong position in its niche areas, particularly with the US Navy, and seeks to expand its market share in medical isotopes and other commercial nuclear services.
Upturn SWOT Analysis
Strengths
- Sole supplier of naval nuclear reactors to the U.S. Navy
- Strong relationships with government agencies
- High barriers to entry in nuclear manufacturing and services
- Growing medical isotope business
Weaknesses
- Dependence on government contracts
- Exposure to regulatory changes
- Capital intensive operations
- Potential for environmental liabilities
Opportunities
- Expansion of medical isotope production capacity
- Growth in demand for advanced nuclear technologies
- International expansion of nuclear services
- Increasing demand for waste processing services
Threats
- Budget cuts in defense spending
- Delays in nuclear power plant projects
- Increased competition in medical isotopes
- Changes in nuclear regulations
Competitors and Market Share
Key Competitors
- CAMECO (CCJ)
- FLUOR (FLR)
- JACOBS ENGINEERING (J)
Competitive Landscape
BWXT holds a strong position in specialized nuclear manufacturing and services due to its unique capabilities and relationships. It faces competition from larger engineering and construction firms in some service areas.
Major Acquisitions
Lynchburg
- Year: 2015
- Acquisition Price (USD millions): 0.18
- Strategic Rationale: Expanded the company's capabilities in nuclear engineering and design.
Growth Trajectory and Initiatives
Historical Growth: BWXT has experienced steady growth driven by defense spending and nuclear services. Growth in past 5 years is 10%.
Future Projections: Analysts project continued growth in revenue and earnings driven by defense programs and the medical isotope business. 5-year growth expectation is 7%
Recent Initiatives: BWXT is investing in expanding its medical isotope production capacity and developing advanced nuclear technologies.
Summary
BWXT is a strong company with a secure position in the naval nuclear reactor market and growing opportunities in medical isotopes. Its reliance on government contracts poses a risk, but its established relationships and specialized capabilities provide a competitive advantage. The company needs to watch out for budget cuts and the growth of competition in its Medical Isotope division. Long-term nuclear trends should ensure future sustainability. Diversification remains key for BWXT in the future.
Peer Comparison
Sources and Disclaimers
Data Sources:
- BWX Technologies Inc. Investor Relations
- Financial News Outlets
- Industry Reports
- Analyst Reports
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market conditions are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About BWX Technologies Inc
Exchange NYSE | Headquaters Lynchburg, VA, United States | ||
IPO Launch date 2010-08-02 | President, CEO & Director Mr. Rex D. Geveden | ||
Sector Industrials | Industry Aerospace & Defense | Full time employees 8700 | Website https://www.bwxt.com |
Full time employees 8700 | Website https://www.bwxt.com | ||
BWX Technologies, Inc. manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The company manufactures precision naval nuclear components, reactors, and nuclear fuel; close-tolerance and high-quality equipment for nuclear applications; critical nuclear components, fuels and assemblies for government and limited other uses; down blend government stockpiles of uranium; and fabricate fuel-bearing precision components. It also supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers; research reactor fuel elements for colleges, universities, and national laboratories; and components for defense applications. In addition, the company manufactures commercial nuclear steam generators, nuclear fuel, fuel handling systems, pressure vessels, reactor components, heat exchangers, tooling delivery systems; and containers for the storage of nuclear fuel and other high-level nuclear waste. Further, it supplies nuclear fuel, fuel handling systems, tooling delivery systems, nuclear-grade materials and precisely machined components; and manufactures medical radioisotopes, radiopharmaceuticals, and medical devices. Additionally, it provides specialized engineering services that include structural component design, 3-D thermal-hydraulic engineering analysis, weld and robotic process development, electrical and controls engineering and metallurgy and materials engineering; in-plant inspection, maintenance and modification services; and non-destructive examination and tooling/repair solutions. It also offers nuclear power plant lifecycle support services. The company was formerly known as The Babcock & Wilcox Company and changed its name to BWX Technologies, Inc. in June 2015. BWX Technologies, Inc. was founded in 1867 and is headquartered in Lynchburg, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.